Loading…
Association of Interleukin-17A rs2275913 Polymorphism with Recurrent Miscarriage: A Systematic Review and Meta-Analysis Study
Recurrent miscarriage (RM) is a condition defined as having three or more consecutive pregnancy losses before the 20 weeks of pregnancy. The present study was undertaken to investigate association of rs2275913 polymorphism with RM. To this end, we searched the international databases (Web of Science...
Saved in:
Published in: | International journal of fertility & sterility 2024-01, Vol.18 (1), p.7-11 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Recurrent miscarriage (RM) is a condition defined as having three or more consecutive pregnancy losses before the 20 weeks of pregnancy. The present study was undertaken to investigate association of
rs2275913 polymorphism with RM. To this end, we searched the international databases (Web of Science, PubMed, Embase, and Scopus) and extracted studies investigating the association of
rs2275913 polymorphism with RM using the appropriate keywords. The collected data were analyzed with the random-effects model and STATA (version 14). A total of five studies met the eligibility criteria, and total sample size was 998 subjects. Mean age of the cases and controls were 31.41 ± 4.16 and 30.56 ± 3.5 years, respectively. Our results disclosed a significant relationship of the
rs2275913 AA genotype [odds ratio (OR)=1.68; 95% confidence interval (CI)=1.16- 2.43; I2=19; P=0.294) with RM. There was no statistically significant correlation between
rs2275913 GG genotype (OR=1.04; 95% CI=0.64-1.7; I
=59.5; P=0.042) and GA genotype (OR=0.85; 95% CI=0.65-1.1
; I
=19.1; P=0.293) with RM. Our findings revealed that the
rs2275913 polymorphism is associated with RM, and the AA genotype of this polymorphism increased possibility of being involved in RM. |
---|---|
ISSN: | 2008-076X 2008-0778 |
DOI: | 10.22074/IJFS.2023.546127.1248 |